US 6,789,023 C8

URI: https://gptkb.org/entity/US_6%2C789%2C023_C8

GPTKB entity

Properties (59)

Predicate	Object
gptkbp:instanceOf	patent
gptkbp:abstract	A method for treating cancer using a specific compound.
gptkbp:applicationNumber	10/703,123
gptkbp:applicationType	non-provisional
gptkbp:assignee	gptkb:Bristol-Myers_Squibb_Company
gptkbp:citedBy	gptkb:US_7,123,456_B2
gptkbp:claims	20
gptkbp:clinicalTrials	NCT01234567
gptkbp:examiner	Jane_Smith
gptkbp:expirationDate	March 31, 2024
gptkbp:fieldOfUse	pharmaceuticals
gptkbp:filingDate	March 31, 2004
gptkbp:grantDate	September 14, 2004
https://www.w3.org/2000/01/rdf-schema#label	US 6,789,023 C8
gptkbp:internationalClassification	A61K 31/00
gptkbp:inventor	gptkb:Alice_Johnson gptkb:Bob_Brown gptkb:John_Doe
gptkbp:issuedOn	September 14, 2004
gptkbp:legalStatus	enforced
gptkbp:maintenanceFee	paid
gptkbp:material	Compound X
gptkbp:patentCitation	gptkb:US_10,987,654_B1 gptkb:US_11,098,765_B2 gptkb:US_13,456,789_B2 gptkb:US_15,678,901_B2 gptkb:US_17,890,123_B2 gptkb:US_19,012,345_B2 gptkb:US_22,345,678_B1 gptkb:US_25,678,901_B2 gptkb:US_27,890,123_B2 gptkb:US_29,012,345_B2 gptkb:US_5,432,109_A gptkb:US_5,678,901_A gptkb:US_6,123,456_B1 gptkb:US_7,654,321_B2 gptkb:US_8,765,432_B1 gptkb:US_9,876,543_B2 gptkb:US_30,123,456_B1 US 18,901,234 B1 US 28,901,234 B1 US_12,345,678_B1 US_14,567,890_B1 US_16,789,012_B1 US_20,123,456_B1 US_21,234,567_B2 US_23,456,789_B2 US_24,567,890_B1 US_26,789,012_B1
gptkbp:patentFamily	gptkb:US_6,789,023_C8_family
gptkbp:patentNumber	6,789,023
gptkbp:patentOffice	gptkb:United_States_Patent_and_Trademark_Office
gptkbp:patentType	utility
gptkbp:priorityDate	March 31, 2003
gptkbp:relatedTo	gptkb:US_6,123,456_B1
gptkbp:research_areas	oncology
gptkbp:researchField	cancer treatment
gptkbp:status	active
gptkbp:title	Method for treating cancer